Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

von Abdul Razak, Albiruni Ryan, Li, Louise, Bryant, Andrew, Diaz-Padilla, Ivan
Veröffentlicht 2011

Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer

von Castonguay, Vincent, Wilson, Michelle K., Diaz‐Padilla, Ivan, Wang, Lisa, Oza, Amit M.
Veröffentlicht in Cancer (2014)

Safety and tolerance of enteral nutrition in COVID-19 critically ill patients, a retrospective study

von Osuna-Padilla, Iván, Rodríguez-Moguel, Nadia Carolina, Aguilar-Vargas, Adriana, Rodríguez-Llamazares, Sebastián
Veröffentlicht in Clin Nutr ESPEN (2021)

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment

von Patrono, María Guadalupe, Minig, Lucas, Diaz-Padilla, Ivan, Romero, Nuria, Rodriguez Moreno, Juan Francisco, Garcia-Donas, Jesus
Veröffentlicht 2013

Fatal respiratory disease due to a homozygous intronic ABCA3 mutation: a case report

von Pachajoa, Harry, Ruiz-Botero, Felipe, Meza-Escobar, Luis Enrique, Villota-Delgado, Vania Alexandra, Ballesteros, Adriana, Padilla, Ivan, Duarte, Diana
Veröffentlicht in J Med Case Rep (2016)

Alcohol and tobacco consumption concordance and its correlates in older couples in Latin America

von Machado, Mayra Pires Alves, Opaleye, Davi Camara, Pereira, Tiago Veiga, Padilla, Ivan, Noto, Ana Regina, Prince, Martin, Ferri, Cleusa Pinheiro
Veröffentlicht in Geriatr Gerontol Int (2017)

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

von van Bussel, Mark T. J., Awada, Ahmad, de Jonge, Maja J. A., Mau-Sørensen, Morten, Nielsen, Dorte, Schöffski, Patrick, Verheul, Henk M. W., Sarholz, Barbara, Berghoff, Karin, El Bawab, Samer, Kuipers, Mirjam, Damstrup, Lars, Diaz-Padilla, Ivan, Schellens, Jan H. M.
Veröffentlicht in Br J Cancer (2020)

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)

von Chiu, Joanne W., Hotte, Sebastien J., Kollmannsberger, Christian K., Renouf, Daniel J., Cescon, David W., Hedley, David, Chow, Sue, Moscow, Jeffrey, Chen, Zhuo, Perry, Meghan, Diaz-Padilla, Ivan, Tan, David, Hirte, Hal, McWhirter, Elaine, Chen, Helen, Siu, Lillian L., Bedard, Philippe L.
Veröffentlicht in Invest New Drugs (2015)

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

von Diaz-Padilla, Ivan, Hirte, Hal, Oza, Amit M., Clarke, Blaise A., Cohen, Brenda, Reedjik, Michael, Zhang, Tong, Kamel-Reid, Suzanne, Ivy, S. Percy, Hotte, Sebastien J., Razak, Albiruni A. R., Chen, Eric X., Brana, Irene, Wizemann, Monika, Wang, Lisa, Siu, Lillian L., Bedard, Philippe L.
Veröffentlicht 2013

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

von Mayer, Ingrid A., Prat, Aleix, Egle, Daniel, Blau, Sibel, Perez Fidalgo, J. Alejandro, Gnant, Michael, Fasching, Peter A., Colleoni, Marco, Wolff, Antonio C., Winer, Eric P., Singer, Christian F., Hurvitz, Sara, Estevez, Laura Garcia, van Dam, Peter A., Kümmel, Sherko, Mundhenke, Christoph, Holmes, Frankie, Babbar, Naveen, Charbonnier, Laure, Diaz-Padilla, Ivan, Vogl, Florian D., Sellami, Dalila, Arteaga, Carlos L.
Veröffentlicht in Clin Cancer Res (2019)

Ovarian Cancer

Veröffentlicht 2013